Showing results (1471-1480 of 3,523) with videos related to

Sort By:
Pageof 353
Genetics and Molecular Research : GMR|July 1, 2015
Effect of atorvastatin on diabetic rat endothelial cells and retinal lesionsM C Bi, X J Song, H Shi, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|February 28, 2018
[Accuracy analysis of alveolar dehiscence and fenestration of maxillary anterior teeth of Angle class III by cone-beam CT]X Xu, L Xu, J H Jiang, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|December 25, 2004
[Investigation on hepatitis G virus (HGV) infection among different populations in Shenzhen]B Zhou, W Ma, H Wang, et al.
The British Journal of Ophthalmology|February 22, 2005
Non-specific tolerance induced by staphylococcal enterotoxin B in treating high risk corneal transplantation in ratsY Jie, Z Pan, Y Chen, et al.
Acta Virologica|July 3, 2004
Serological characterization of a hantavirus from Hubei, ChinaF L Xu, Z Q Yang, C C Yang, et al.
Genetics and Molecular Research : GMR|September 9, 2015
Highly specific detection of genetic modification events using an enzyme-linked probe hybridization chipM Z Zhang, X F Zhang, X M Chen, et al.
The Journal of Biological Chemistry|September 22, 1995
Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors. C-C CKR1, a receptor for macrophage inflammatory protein-1 alpha/Rantes, is also a functional receptor for MCP3A Ben-Baruch, L Xu, P R Young, et al.
Anticancer Research|January 19, 1999
Metallothionein and apoptosis in primary human hepatocellular carcinoma (HCC) from northern ChinaL Cai, G J Wang, Z L Xu, et al.
Transplantation Proceedings|November 18, 2009
Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control studyX Zhu, J Chen, F Han, et al.
Cancer Chemotherapy and Pharmacology|May 12, 2017
FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancerY L Xu, R Yao, J Li, et al.
Pageof 353